Mauro Viganò

High rates of 30-day mortality in patients with cirrhosis and COVID-19

Massimo Iavarone, Roberta D’Ambrosio, Alessandro Soria et al. · Journal of Hepatology · 2020 · 388 citations · Full text

Hepatology, High Rates, Covid-19 Pandemic +8

Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues

Carolina Boni, Diletta Laccabue, Pietro Lampertico et al. · Gastroenterology · 2012 · 358 citations · Full text

Ide Analogues, Medicine, T-regulatory Cell +9

Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients

Pietro Lampertico, Mauro Viganò, E. Manenti et al. · Gastroenterology · 2007 · 310 citations · Full text

Hepatology, Adefovir Combined, Viral Hepatitis +12

Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine†

Pietro Lampertico, Mauro Viganò, E. Manenti et al. · Hepatology · 2005 · 274 citations

IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen–negative patients with chronic hepatitis B

Pietro Lampertico, Mauro Viganò, Cristina Cheroni et al. · Hepatology · 2012 · 157 citations · Full text